• Study shows efficacy of radionuclide therapy-immunotherapy combination in prostate cancer model

    One year ago - By News Medical

    A combination of radionuclide therapy and immunotherapy has proven successful in slowing the progression of prostate cancer and increasing survival time, according to new research published in the February issue of The Journal of Nuclear Medicine.
    Read more ...